NouBio Inc

NouBio Inc is cell-based human longevity company. We are focused on the bio-intelligent manufacturing of animal serum replacements & artificial intelligence driven biocomputer deep technologies to reduce the costs of cell-based biomanufacturing by 95% & scale the production of novel cell-based human longevity applications. NouBio's deep technologies scale production in the industries of cell-based human longevity including cell-therapies, cell-vaccines, human tissue creation, cell-based blood, drug discovery, regenerative medicine, cell-based foods/materials, defense, & synthetic biology. NouBio raised venture capital investment from Big Idea Ventures & angels. First beta product [Launched 2024]: NouSerum: A full Fetal Bovine Serum (FBS) replacement that reduces production costs by 50-95% whilst maintaining the same performance as FBS. NouSerum: -Has 300 serum proteins found in FBS -Is in the GRAS category of FDA -Free from GMOs -Powder based for scalability -Antimicrobial to reduce contamination -Can be stored at room temperature -GMP compliant Future products: Future products: -Cost-effective, bio-degradable microcarriers with no need to remove cells in bioreactors. -An artificial intelligence driven robotic cellular biocomputer to create cell-based longevity products & scale production. -Artificial intelligence driven formulas and ingredients for enhanced cell-based products (including XenoFree products). Email info@noubio.co for more information